Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST IRCCS

Meldola 47014

0 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, EGFR Exon 20 Mutation, Follicular Lymphoma, Gastro-enteropancreatic Neuroendocrine Tumor, Non Small Cell Lung Cancer, Non-Hodgkin Lymphoma, Non-Small Cell Lung Cancer, Peripheral T Cell Lymphoma, Transformed Mycosis Fungoides

Studies at this site

• A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET — Running, not enrolling
• A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer — Running, not enrolling
• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1) — Running, not enrolling
• Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides — Completed
• A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma — Completed